
|Articles|January 1, 2007
Eye on Washington
Author(s)Judith Asch-Goodkin
Advertisement
When the new Congress gets down to business this month, change will be in the air. With majorities in the House and, maybe, the Senate, the Democrats will have an opportunity to enact their vision of health care reform. It will be interesting to see what they do with it. For starters, incoming House Speaker Nancy Pelosi has already promised to introduce legislation that would allow the Centers for Medicare and Medicaid Services (CMS) to negotiate discounts on drug prices and to provide federal funding for stem cell research.
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Julie Khlevner, MD, discusses the impact of FDA-approved LINZESS for functional constipation
2
Recognizing the skin findings that distinguish pediatric hidradenitis suppurativa
3
FDA approves ensitrelvir for post-exposure prevention of COVID-19 in adolescents and adults
4
Colleen Cotton, MD, on the importance of early recognition in hidradenitis suppurativa
5




